Z-1689-2025 Class II Ongoing

Recalled by Boston Scientific Corporation — Maple Grove, MN

FDA device recall Z-1689-2025 was initiated by Boston Scientific Corporation on Mar 24, 2025 and is designated Class II. Reason for recall: Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings (see Affected… The recall status is ongoing. Affected quantity: 67 units.

Recall details

Product Type
Devices
Report Date
May 7, 2025
Initiation Date
Mar 24, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
67 units

Product description

IceSeed 1.5 CX NEEDLE OUS, Cryoablation Needle, REF H7493967534170. The needles are intended to convert high-pressure gas to either a very cold Freezing application or to a warm Thawing application.

Reason for recall

Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings (see Affected Product Listing). Upon initial connection of an IceSeed CX needle to the Cryoablation System, the user will be prompted to perform the Needle Integrity and Functionality Test (NIT) per standard protocols. The affected needles perform as intended unless they are disconnected and reconnected to any channel after testing. In this case, the Cryoablation System will prompt re-execution of the NIT.

Distribution pattern

Nationwide

Code information

GTIN00191506032708, Batch Numbers: 33988638, 33988639, 34309895, 34309896, 34392269, 34392270, 34392271, 34564920.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1689-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1689-2025. Report a data issue: hello@regdatalab.com.